ANTX · AN2 Therapeutics, Inc.

$5.58 -0.16 (-2.79%) At close · Aug 28

Russell 2000 member Rebalance outlook locked

Market Cap

$210.57M

37.74M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-06-04	2026 Jefferies Global Healthcare Conference	Conference
2026-05-19	2026 Stifel Virtual Targeted Oncology Forum	Webcast
2026-03-10	Leerink Global Healthcare Conference	Conference
2026-03-04	AN2 Corporate Update Webcast	Webcast
2025-12-03	8th Annual Evercore Healthcare Conference	Conference
2025-05-07	The Citizens Life Sciences Conference	Conference
2025-03-12	Leerink's Global Healthcare Conference 2025	Conference
2025-03-03	TD Cowen 45th Annual Health Care Conference	Conference
2025-02-12	Oppenheimer 35th Annual Healthcare Life Sciences Conference	Conference
2024-12-04	7th Annual Evercore HealthCONx Conference	Conference
2024-09-10	H.C. Wainwright 26th Annual Global Investment Conference	Conference
2023-11-29	6th Annual Evercore ISI HealthCONx Conference	Conference
2023-11-15	Stifel Healthcare Conference	Conference
2023-06-08	Jefferies Healthcare Conference	Conference
2023-05-16	The JMP Securities Life Sciences Conference	Conference
2023-03-14	Oppenheimer 33RD Annual Healthcare Conference	Conference
2023-03-07	Cowen 43RD Annual Health Care Conference	Conference
2023-02-14	SVB Securities Global Biopharma Conference	Conference
2022-11-30	Evercore ISI HealthCONx Conference	Conference
2022-11-16	Stifel Healthcare Conference	Conference
2022-09-12	H.C. Wainwright 24th Annual Global Investment Conference	Conference

Source: https://investor.an2therapeutics.com/

Key facts CIK 1880438 CUSIP 037326105 13F (30d) 62 filings 62 filers Visit website Investor relations